Abstract
Journal of Cancer Metastasis and Treatment is an open access journal, focusing on basic and clinical studies related to cancer cell, cell biology, oncology, radiation therapy and radiology, obstetrics and gynecology, pediatrics, surgery, hematology, neuro-oncology, etc.
Highlights
Gastric cancer is the fourth most common cancer in the world with a 5-year survival rate of 25%[1,2]
There have been randomized and non-randomized trials about adjuvant perioperative intraperitoneal chemotherapy compared to surgery alone for resectable primary gastric cancer without peritoneal spread
There is potential for long-term survival for patients with gastric cancer and peritoneal metastases with the combined use of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)
Summary
Gastric cancer is the fourth most common cancer in the world with a 5-year survival rate of 25%[1,2]. There have been randomized and non-randomized trials about adjuvant perioperative intraperitoneal chemotherapy compared to surgery alone for resectable primary gastric cancer without peritoneal spread. There may be some effective palliation of gastric cancer resections in patients with peritoneal metastases, there is no long-term improvement in survival.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
